Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QNCX

Quince Therapeutics (QNCX)

Quince Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QNCX
DateTimeSourceHeadlineSymbolCompany
12/27/20243:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:QNCXQuince Therapeutics Inc
12/26/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QNCXQuince Therapeutics Inc
12/18/20243:03PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:QNCXQuince Therapeutics Inc
11/14/20245:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNCXQuince Therapeutics Inc
11/13/20248:17PMEdgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:QNCXQuince Therapeutics Inc
11/13/20244:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNCXQuince Therapeutics Inc
11/13/20243:05PMBusiness WireQuince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:QNCXQuince Therapeutics Inc
11/12/20243:05PMBusiness WireQuince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia ResearchNASDAQ:QNCXQuince Therapeutics Inc
11/11/20243:05PMBusiness WireQuince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual MeetingNASDAQ:QNCXQuince Therapeutics Inc
10/14/20243:05PMBusiness WireQuince Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:QNCXQuince Therapeutics Inc
09/03/20243:05PMBusiness WireQuince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:QNCXQuince Therapeutics Inc
08/21/20245:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNCXQuince Therapeutics Inc
08/15/20246:00AMBusiness WireQuince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T)NASDAQ:QNCXQuince Therapeutics Inc
08/13/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNCXQuince Therapeutics Inc
08/13/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNCXQuince Therapeutics Inc
08/13/20243:05PMBusiness WireQuince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:QNCXQuince Therapeutics Inc
06/25/20246:00AMBusiness WireQuince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-TelangiectasiaNASDAQ:QNCXQuince Therapeutics Inc
06/07/20248:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNCXQuince Therapeutics Inc
06/07/20248:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNCXQuince Therapeutics Inc
06/07/20247:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNCXQuince Therapeutics Inc
06/06/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNCXQuince Therapeutics Inc
06/05/20241:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QNCXQuince Therapeutics Inc
06/03/20246:00AMBusiness WireQuince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex SystemNASDAQ:QNCXQuince Therapeutics Inc
05/13/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNCXQuince Therapeutics Inc
05/13/20246:00AMBusiness WireQuince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial ResultsNASDAQ:QNCXQuince Therapeutics Inc
05/06/20243:05PMBusiness WireQuince Therapeutics to Present at The Citizens JMP Life Sciences ConferenceNASDAQ:QNCXQuince Therapeutics Inc
04/01/20246:00AMBusiness WireQuince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial ResultsNASDAQ:QNCXQuince Therapeutics Inc
02/22/20246:00AMBusiness WireQuince Therapeutics Launches Scientific Advisory BoardNASDAQ:QNCXQuince Therapeutics Inc
02/15/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNCXQuince Therapeutics Inc
02/15/20246:00AMBusiness WireQuince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of DirectorsNASDAQ:QNCXQuince Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:QNCX

Your Recent History

Delayed Upgrade Clock